ARTICLE SUMMARY:
In this week’s roundup: CMS rolls out a long-awaited proposed rule that would grant four years of automatic coverage to FDA-approved Breakthrough Devices; UK policymakers flesh out new, post-Brexit regulatory horizons for devices; a new science chief at CDRH, and more.
A years-in-the-making proposal to grant automatic, though temporary, Medicare coverage to FDA-approved Breakthough Devices is finally out in the open. We dig into that CMS plan, look at new details about post-Brexit device regulation in the UK, and more in the latest edition of Pathways’ Picks.
